← Research library

Peptide Regulation of Chondrogenic Stem Cell Differentiation

Review of earlier studies · 2023

What was studied
Review of stem-cell differentiation and cartilage research
Main finding
Describes the cartilage polypeptide complex PCC and its AED component. The authors reported a Russian Phase II osteoarthritis program in 2023. They connect MSC and fibroblast findings to a cartilage-repair hypothesis.

Study data at a glance

Participants or experimental model
Review of stem-cell differentiation and cartilage research
Reported results
Describes the cartilage polypeptide complex PCC and its AED component. The authors reported a Russian Phase II osteoarthritis program in 2023. They connect MSC and fibroblast findings to a cartilage-repair hypothesis.
Study limitations and source details

Study limitations

  • The reported trial concerns PCC, not a trial of isolated Cartalax.
  • Trial identifier, protocol, enrollment and published human outcomes have not been recovered. Phase II is an attributed 2023 statement, not verified current status.

Source details

Full-text XML checked, including PCC/AED discussion and references 7, 9, 68–70. Trial documents were not supplied by this review.

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology

ReviewFull text available

Linkova N, Khavinson V, Diatlova A, Myakisheva S, Ryzhak G. Peptide Regulation of Chondrogenic Stem Cell Differentiation Int J Mol Sci 24(9):8415. PMID 37176122

Study source ↗ · DOI 10.3390/ijms24098415 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards